On this page you'll find 10+ example sentences with Regeneron. Discover how to use the word correctly in a sentence.
Regeneron in a sentence
Using Regeneron
- In the example corpus, regeneron often appears in combinations such as: regeneron pharmaceuticals, of regeneron, in regeneron.
Context around Regeneron
- Average sentence length in these examples: 21.6 words
- Position in the sentence: 7 start, 12 middle, 1 end
- Sentence types: 20 statements, 0 questions, 0 exclamations
Corpus analysis for Regeneron
- In this selection, "regeneron" usually appears in the middle of the sentence. The average example has 21.6 words, and this corpus slice is mostly made up of statements.
- Around the word, data, part, pharmaceuticals and says stand out and add context to how "regeneron" is used.
- Recognizable usage signals include shares of regeneron pharmaceuticals by and holdings in regeneron pharmaceuticals were. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "regeneron" sits close to words such as aas, abdicated and abled, which helps place it inside the broader word index.
Example types with regeneron
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
For its part, Regeneron says it plans to work with the FDA to address its concerns. (16 words)
Regeneron Pharmaceuticals () is a large cap pharmaceutical company best known for its eye disease therapy Eylea. (16 words)
This deal has Regeneron Pharmaceuticals agreeing to acquire Decibel Therapeutics for $4 per share in cash. (16 words)
Great Lakes Advisors LLC purchased a new position in Regeneron Pharmaceuticals, Inc. () in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). (32 words)
The sale was disclosed in a legal filing with the SEC, which is accessible through sold 250 shares of Regeneron Pharmaceuticals stock in a transaction dated Monday, July 3rd. (29 words)
Finally, Truist Financial reaffirmed a “buy” rating and set a $1,045.00 price objective on shares of Regeneron Pharmaceuticals in a research report on Wednesday, August 16th. (28 words)
Example sentences (20)
According to Seeking Alpha data: Regeneron's capital structure is relatively robust with a small debt figure relative to its market capitalization, and a significant cash position.
Also, CFO Robert E. Landry sold 739 shares of Regeneron Pharmaceuticals stock in a transaction that occurred on Friday, February 3rd.
Cibc World Market Inc. grew its holdings in shares of Regeneron Pharmaceuticals by 1.4% during the 1st quarter.
Dynamic Advisor Solutions LLC’s holdings in Regeneron Pharmaceuticals were worth $299,000 as of its most recent filing with the SEC.
Eqis Capital Management Inc.’s holdings in Regeneron Pharmaceuticals were worth $1,160,000 as of its most recent SEC filing.
Equities research analysts anticipate that Regeneron Pharmaceuticals, Inc. will post 34.05 earnings per share for the current year.
Finally, Plancorp LLC boosted its holdings in shares of Regeneron Pharmaceuticals by 0.8% during the 1st quarter.
Finally, SVB Leerink raised shares of Regeneron Pharmaceuticals from a “market perform” rating to an “outperform” rating in a research note on Monday, March 27th.
Finally, Truist Financial reaffirmed a “buy” rating and set a $1,045.00 price objective on shares of Regeneron Pharmaceuticals in a research report on Wednesday, August 16th.
For its part, Regeneron says it plans to work with the FDA to address its concerns.
Great Lakes Advisors LLC purchased a new position in Regeneron Pharmaceuticals, Inc. () in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC).
Importantly, these anticipated incremental expenses will be reimbursed by Sanofi, generally resulting in a neutral impact to Regeneron's 2023 operating profit.
In other Regeneron Pharmaceuticals news, CFO Robert E. Landry sold 739 shares of the company’s stock in a transaction that occurred on Friday, February 3rd.
In other Regeneron Pharmaceuticals news, CFO sold 223 shares of the firm’s stock in a transaction dated Wednesday, August 23rd.
Regeneron Pharmaceuticals () is a large cap pharmaceutical company best known for its eye disease therapy Eylea.
Renaissance Technologies LLC grew its stake in shares of Regeneron Pharmaceuticals by 108.3% in the second quarter.
SeaCrest Wealth Management LLC bought a new position in Regeneron Pharmaceuticals during the 2nd quarter worth about $40,000.
Sequoia Financial Advisors LLC raised its holdings in Regeneron Pharmaceuticals by 23.1% during the first quarter.
The sale was disclosed in a legal filing with the SEC, which is accessible through sold 250 shares of Regeneron Pharmaceuticals stock in a transaction dated Monday, July 3rd.
This deal has Regeneron Pharmaceuticals agreeing to acquire Decibel Therapeutics for $4 per share in cash.
Common combinations with regeneron
These word pairs occur most frequently in English texts:
- regeneron pharmaceuticals 39×
- of regeneron 13×
- in regeneron 11×
- on regeneron 3×
- the regeneron 3×
- regeneron says 2×
- regeneron said 2×
- that regeneron 2×
- other regeneron 2×
- and regeneron 2×